Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $211.65 | Total: $1,058.25 |
| 1 | 10 | $179.28 | Total: $1,792.80 |
| 1 | 25 | $151.89 | Total: $3,797.25 |
| 1 | 50 | $129.48 | Total: $6,474.00 |
| 1 | 100 | $112.05 | Total: $11,205.00 |
Overview
BMS-823778 is a potent inhibitor of 11?-hydroxysteroid dehydrogenase type 1 (11?-HSD-1) for the study of type 2 diabetes.
Chemical Properties
| Molecular Formula | C18H18ClN3O |
| Molecular Weight | 327.81 |
| CAS Numbers | 1140897-32-0 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | ClC1=CC=C(C=C1)C2(C3=NN=C4C(=CC=CN43)C(O)(C)C)CC2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Li J, et al. Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11?-Hydroxysteroid Dehydrogenase Type 1 [11?-HSD-1]. ACS Med Chem Lett. 2018 Nov 13;9[12] 1170-1174.